HO-1 mediates the rate-limiting step of heme degradation and prevents atherosclerosis by its effect on bilirubin, which reduces lipid peroxidation, but HO-1 also inhibits lesion development in LDLR−/− mice in a lipid-independent manner [169]. This evidence concerns the gene LDLR and atherosclerosis.